These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 25425053)

  • 21. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity.
    Casa DM; Scariot DB; Khalil NM; Nakamura CV; Mainardes RM
    Exp Parasitol; 2018 Sep; 192():12-18. PubMed ID: 30026113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis.
    Kansal S; Tandon R; Dwivedi P; Misra P; Verma PR; Dube A; Mishra PR
    J Antimicrob Chemother; 2012 Nov; 67(11):2650-60. PubMed ID: 22872448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and performance evaluation of alginate-capped amphotericin B lipid nanoconstructs against visceral leishmaniasis.
    Singodia D; Khare P; Dube A; Talegaonkar S; Khar RK; Mishra PR
    J Biomed Nanotechnol; 2011 Feb; 7(1):123-4. PubMed ID: 21485834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antileishmanial activity of nano-amphotericin B deoxycholate.
    Manandhar KD; Yadav TP; Prajapati VK; Kumar S; Rai M; Dube A; Srivastava ON; Sundar S
    J Antimicrob Chemother; 2008 Aug; 62(2):376-80. PubMed ID: 18453526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys.
    Berman JD; Hanson WL; Chapman WL; Alving CR; Lopez-Berestein G
    Antimicrob Agents Chemother; 1986 Dec; 30(6):847-51. PubMed ID: 3813512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: an approach for non-toxic chemotherapy.
    Gupta PK; Jaiswal AK; Asthana S; Teja B V; Shukla P; Shukla M; Sagar N; Dube A; Rath SK; Mishra PR
    Br J Pharmacol; 2015 Jul; 172(14):3596-610. PubMed ID: 25825339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fabrication of 3-O-sn-Phosphatidyl-L-serine Anchored PLGA Nanoparticle Bearing Amphotericin B for Macrophage Targeting.
    Singh PK; Jaiswal AK; Pawar VK; Raval K; Kumar A; Bora HK; Dube A; Chourasia MK
    Pharm Res; 2018 Feb; 35(3):60. PubMed ID: 29427248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting.
    Gupta S; Vyas SP
    J Drug Target; 2007 Apr; 15(3):206-17. PubMed ID: 17454358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanonization increases the antileishmanial efficacy of amphotericin B: an ex vivo approach.
    Manandhar KD; Yadav TP; Prajapati VK; Basukala O; Aganja RP; Dude A; Shrivastav ON; Sundar S
    Adv Exp Med Biol; 2014; 808():77-91. PubMed ID: 24595612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis.
    Nahar M; Dubey V; Mishra D; Mishra PK; Dube A; Jain NK
    J Drug Target; 2010 Feb; 18(2):93-105. PubMed ID: 19640212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis.
    Riezk A; Van Bocxlaer K; Yardley V; Murdan S; Croft SL
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32887341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemoglobin guided nanocarrier for specific delivery of amphotericin B to Leishmania infected macrophage.
    Bose PP; Kumar P; Dwivedi MK
    Acta Trop; 2016 Jun; 158():148-159. PubMed ID: 26945483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis.
    Corral MJ; Serrano DR; Moreno I; Torrado JJ; Domínguez M; Alunda JM
    J Antimicrob Chemother; 2014 Dec; 69(12):3268-74. PubMed ID: 25096077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coating doxorubicin-loaded nanocapsules with alginate enhances therapeutic efficacy against Leishmania in hamsters by inducing Th1-type immune responses.
    Kansal S; Tandon R; Verma A; Misra P; Choudhary AK; Verma R; Verma PR; Dube A; Mishra PR
    Br J Pharmacol; 2014 Sep; 171(17):4038-50. PubMed ID: 24837879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.
    Sánchez-Brunete JA; Dea MA; Rama S; Bolás F; Alunda JM; Raposo R; Méndez MT; Torrado-Santiago S; Torrado JJ
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3246-52. PubMed ID: 15328080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani.
    Chaubey P; Mishra B; Mudavath SL; Patel RR; Chaurasia S; Sundar S; Suvarna V; Monteiro M
    Int J Biol Macromol; 2018 May; 111():109-120. PubMed ID: 29307805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mannosylated liposomes bearing Amphotericin B for effective management of visceral Leishmaniasis.
    Rathore A; Jain A; Gulbake A; Shilpi S; Khare P; Jain A; Jain SK
    J Liposome Res; 2011 Dec; 21(4):333-40. PubMed ID: 21612342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis.
    Parvez S; Yadagiri G; Gedda MR; Singh A; Singh OP; Verma A; Sundar S; Mudavath SL
    Sci Rep; 2020 Jul; 10(1):12243. PubMed ID: 32699361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and antileishmanial activity of amphotericin B-loaded stable ionic amphiphile biovector formulations.
    Loiseau PM; Imbertie L; Bories C; Betbeder D; De Miguel I
    Antimicrob Agents Chemother; 2002 May; 46(5):1597-601. PubMed ID: 11959611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.